Rockville, April 13, 2023 (GLOBE NEWSWIRE) -- As per the latest estimates by Fact.MR, a market research and competitive intelligence provider, the global artificial kidney market is valued at US$ 1.5 billion in 2023 and is predicted to expand rapidly at a CAGR of 13% from 2023 to 2033.
Artificial kidneys are medical devices that are designed to mimic the functions of a human kidney. These devices are used to treat patients with end-stage renal disease (ESRD), a condition where the kidneys fail to function properly. The global artificial kidney market is expected to grow at a significant rate over the coming years due to the increasing prevalence of ESRD and rising demand for renal replacement therapies.
- According to the Centers for Disease Control & Prevention Report 2021, more than 37 million Americans are living with chronic kidney disease.
Rising prevalence of diabetes and hypertension, which are the leading causes of kidney failure, is further contributing to the growth of the artificial kidney market. Another factor driving the growth of the market is the increasing adoption of home-based dialysis treatments.
Get Free Sample Report to Grow Your Profit Margin – https://www.factmr.com/connectus/sample?flag=S&rep_id=8509
Home-based dialysis treatments provide patients with greater convenience and are also more cost-effective than in-center treatments. As a result, more patients are opting for home-based dialysis treatments, which are driving demand for portable and lightweight artificial kidney devices.
Key Takeaways from Market Study
- The artificial kidney market is expected to reach US$ 5.3 billion by 2033.
- In North America, sales of artificial kidneys are predicted to increase at a rapid pace due to the presence of advanced healthcare facilities and key market players.
- Growing cases of kidney-related disorders in China are increasing the adoption rates of advanced artificial kidneys.
- Wearable artificial kidneys are becoming a popular form of peritoneal dialysis method as they require less technical support.
- Hospitals are leading the sales of artificial kidneys due to the high intake of target patients.
“Introduction of advanced portable bio-artificial kidneys is expected to boost demand graph upwards at a rapid pace,” says a Fact.MR analyst.
Key Segments of Artificial Kidney Industry Research
- By Type :
- Wearable Artificial Kidneys
- Implantable Artificial Kidneys
- By Dialysis :
- Hemodialysis
- Peritoneal Dialysis
- Combination
- By Application :
- Adults
- Pediatrics
- By End User :
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=8509
| Report Attributes | Details |
| Artificial Kidney Market Size (2023E) | US$ 1.5 Billion |
| Forecasted Market Value (2033F) | US$ 5.3 Billion |
| Global Market Growth Rate (2023 to 2033) | 13% CAGR |
| Leading Regional Market | North America |
| No. of Pages | 170 Pages |
| No. of Tables | 80 Tables |
| No. of Figures | 219 Figures |
Competitive Analysis
Technological advancements in artificial kidney devices are also contributing to the growth of the market. Key players in the artificial kidney market are working on developing improved implantable artificial kidneys that are capable to function as natural kidneys. These devices are expected to offer significant benefits over traditional dialysis treatments, including improved quality of life and reduced healthcare costs, which may further aid manufacturers of artificial kidneys to earn more.
Key Companies Profiled
- Kawasumi Laboratories Inc.
- Nanodialysis B.V.
- Fresenius SE & Co KGaA
- Baxter
- Asahi Kasei Medical Co., Ltd.
- Medtronic
- DaVita Inc
- Merit Medical Systems
- Nipro Medical Corporation
- Nikkiso Co Ltd
- B. Braun Melsungen AG
- AWAK Technologies
Explore Our Safe & Secure Payment Options for Quick Buy – https://www.factmr.com/checkout/8509
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global artificial kidney market, presenting historical demand data (2018 to 2022) and forecast statistics for the period (2023 to 2033).
The study divulges essential insights on the market based on type (wearable artificial kidneys, implantable artificial kidneys), dialysis (hemodialysis, peritoneal dialysis, combination), application (adults, pediatrics), and end user (hospitals, specialty clinics, ambulatory surgical centers), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Cosmetic Surgery and Procedure Market: The global cosmetic surgery and procedure market is forecasted to expand at a high-value CAGR of 9.8% from 2022 to 2030. Revenue from the market in 2022 is valued at US$ 69.2 billion and is projected to climb to US$ 146.5 billion by the end of 2030.
Pathology Instruments Market: The global pathology instruments market is valued at US$ 3.65 billion in 2023 and is predicted to reach US$ 5.67 billion by the end of 2033. Rising prevalence of contagious and chronic diseases across the world is expected to increase the sales of pathology instruments at a CAGR of 4.5% during the next 10 years.
Cardiovascular Disease Monitoring and Diagnostic Devices Market: The global cardiovascular disease monitoring and diagnostic devices market is projected to rise at a CAGR of 6% from 2022 to 2027. The market is expected to secure a market value of around US$ 4.2 billion by 2027, up from US$ 3.14 billion in 2022. Increasing prevalence of chronic cardiovascular diseases across the world is the major driver of the global cardiovascular disease monitoring devices market.
Cell Line Development Market: The value of the global cell line development market stands at US$ 4.97 billion in 2023 and is projected to reach a valuation of US$ 8.2 billion by the end of 2033. Over the next ten years, Fact.MR’s research projects global demand for cell line development to rise at 5.1% CAGR.
Dyslipidemia Therapeutics Market: The global dyslipidemia therapeutics market is valued at US$ 41.55 billion in 2023 and is forecasted to exhibit expansion at a CAGR of 2.5% over the next ten years. This Fact.MR market study predicts global demand for dyslipidemia therapeutics to accumulate a market revenue of US$ 53.2 billion by the end of 2033.
About Us:
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Connect to Author: Shambhu Nath Jha
Email : shambhu@factmr.com
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | YouTube
